Is CADL stock safe? | Glauxie AI

Q: Is CADL stock safe?

Candel Therapeutics, Inc. (CADL) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Paul-Peter Tak. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical... Employees: 64,050.

Q: What are the risks of investing in CADL?

Identify key risks of investing in CADL — debt, competition, volatility, and sector headwinds.

Q: Is CADL a good long-term investment?

Evaluate CADL as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does CADL have?

Review CADL total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is CADL stock safe?

🦉

Candel Therapeutics, Inc. (CADL)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOPaul-Peter Tak

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of...

Key Executives

Name	Title
Charles Schoch	Senior VP, CFO, Treasurer & Secretary
Francesca Barone	Chief Scientific Officer
Ileen Winick	Chief People Officer
Paul-Peter Tak FOCIS	President, Chief Executive Officer & Director
Seshu Tyagarajan	Chief Technical & Development Officer
Susan Stewart	Chief Regulatory Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CADL Profile Financials

What are the risks of investing in CADL? Is CADL a good long-term investment? How much debt does CADL have?